Ignite Creation Date:
2024-05-06 @ 3:16 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02248571
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2014-08-28
Brief Title:
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Sponsor:
iOMEDICO AG
Organization:
iOMEDICO AG
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hormone Receptor Positive Malignant Neoplasm of Breast |
| Breast Cancer Recurrent |
| HER2Neu-negative Carcinoma of Breast |